Combination use of HAIC and ICIs was also associated with reduced risk of death although this did not reach statistical significance (adjusted HR: 0.47; 95% CI: 0.21–1.04; P=0.062) ( Table S5 ).
← all excerpts
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan.
1
0.0620
0.0620